Study of Selinexor Plus DRd for Newly Diagnosed Multiple Myeloma
Public ClinicalTrials.gov record NCT04782687. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II Trial of Daratumumab, Lenalidomide and Dexamethasone (DRd) in Combination With Selinexor for Patients With Newly Diagnosed Multiple Myeloma
Study identification
- NCT ID
- NCT04782687
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- US Oncology Research
- Industry
- Enrollment
- 73 participants
Conditions and interventions
Conditions
Interventions
- Daratumumab Drug
- Dexamethasone Oral Drug
- Lenalidomide Drug
- Selinexor Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Not listed
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 9, 2021
- Primary completion
- May 30, 2026
- Completion
- May 30, 2026
- Last update posted
- Jan 15, 2025
2021 – 2026
United States locations
- U.S. sites
- 10
- U.S. states
- 7
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arizona Oncology Associates, PC - HOPE | Tucson | Arizona | 85711 | — |
| Rocky Mountain Cancer Centers | Denver | Colorado | 80218 | — |
| Maryland Oncology Hematology, P.A. | Columbia | Maryland | 21044 | — |
| New York Oncology Hematology, P.C. | Albany | New York | 12206 | — |
| Willamette Valley Cancer Institute and Research Center | Eugene | Oregon | 97401 | — |
| Texas Oncology, P.A. | Austin | Texas | 78705 | — |
| Texas Oncology, P.A. | Fort Worth | Texas | 76104 | — |
| Texas Oncology, P.A. | San Antonio | Texas | 78240 | — |
| Texas Oncology, P.A. | Tyler | Texas | 75702 | — |
| Virginia Cancer Specialists, PC | Gainesville | Virginia | 20155 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04782687, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 15, 2025 · Synced Apr 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04782687 live on ClinicalTrials.gov.